The Translational Medicine Group connects academia and industry to accelerate the development of novel therapeutics. We focus on efficient resource utilization and tightly coordinated itmelines that distinguish us from traditional academic collaborations.
Our leadership team is comprised of experienced clinicians and research scientists with a thorough understanding of drug and medical device development and the best practices of both academia and industry
The Translational Research Center at MGH is a state-of-the-art facility that expedites proof-of-concept clinical testing for new molecular entities and cost effectively delivers drug candidates with decreased risk for phase 2b or 3 trials
The Translational Medical Group is located at Massachusetts General Hospital, the largest teaching hospital of the Harvard Medical School. Our unique position within a leading academic medical center enables us to combine the best practices of academia and industry to design innovative therapeutic development programs with the Boston biomedical community. Strategic elements of our collaborative translational partnerships include: